Pharmacological perspective to mitigate the COVID-19 management in the Alzheimer’s Disease and Related Dementia: An update

Registration ID: IJNRD_180558

Published ID: IJNRD2203002

DOI: Click Here to Get

Subhasish Sahoo , Diptirani Rath

COVID-19, Alzheimer’s disease, Cognitive impairment, pulmonary diseases, risk factors, Geriatric vaccination.

Background COVID-19 was found in late 2019 which causes severe respiratory illness. Cognitive impairment patients who are suffering from Alzheimer’s Disease and Related Dementias (ADRD) are having a higher risk of COVID infection and other pulmonary diseases leading to a high mortality rate. A risk factor is the ‘age’ that forms a link between Alzheimer’s and the morbidity related to COVID 19. This perspective encloses the measures which may help to mitigate the management of COVID-19 in Alzheimer’s Disease and Related Dementias (ADRD). The article updates primarily on prevalence, incidence, associated risk factors, supervision, and care for patients suffering from ADRD which can help to decrease the burden on the patients suffering from ADRD. Methods This article was reviewed referring to websites like Scopus, Google Scholar, ScienceDirect, PubMed, MedKnow Publications, NCBI.NLM.NIH, EBSCO, Web of Science, etc. Results and Discussion It was illustrated by various cases of COVID 19 that people with elderly i.e., above 70 years were at high risk of mortality due to weaker immune system, synaptic loss, and impaired cognition. Mortality due to pneumonia is twice more prevalent in dementia patients than in the without dementia. Smoking is another risk factor for AD in elderly persons. According to the previous cases reported, it was found that people who were taking high consumption of fish, omega-3-polyunsaturated fatty acid diet linked to lessen the chances of AD and dementia-like symptoms. Patients with AD and related dementia should be encouraged for virtual meeting/ e-consultation/ telemedicine/ online mental health programs instead of clinical visits. Vaccination would greatly assist geriatric people during the COVID-19 pandemic which may help them to overcome the infection.

Published Paper   E-Certificate

Subhasish Sahoo & Diptirani Rath (March-2022). Pharmacological perspective to mitigate the COVID-19 management in the Alzheimer’s Disease and Related Dementia: An update. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 7(3), 27-31. https://ijnrd.org/papers/IJNRD2203002.pdf

Volume 7 Issue 3, March-2022

Pages : 27-31

Paper Reg. ID: IJNRD_180558

Published Paper Id: IJNRD2203002

Downloads: 000121981

Research Area: Pharmacy

Country: Bhubaneswar, Odisha, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2203002.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2203002

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details